Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-129263

Chief Accounting Officer sold 554 shares at $0.55 ($304)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-19 Sale : show line 1 in the form −554 $0.55 $304 68,506 D
Open-market sales · 554 sh · avg $0.55 · $304
Loading xslF345X05/ownership.xml…